1
|
Crooks MG, Cummings H, Morice AH, Sykes D, Brooks S, Jackson A, Xu Y. Reducing short-acting beta-agonist use in asthma: Impact of national incentives on prescribing practices in England and the findings from SENTINEL Plus early adopter sites. NPJ Prim Care Respir Med 2024; 34:6. [PMID: 38684652 PMCID: PMC11058200 DOI: 10.1038/s41533-024-00363-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Accepted: 04/10/2024] [Indexed: 05/02/2024] Open
Abstract
Short-acting beta-agonist (SABA) over-use in asthma is harmful for patients and the environment. The Investment and Impact Fund (IIF) 2022/2023 financially rewarded English primary care networks that achieved specific targets, including reducing SABA over-use (RESP-02) and lowering the mean carbon footprint per salbutamol inhaler prescribed (ES-02). SENTINEL Plus is a co-designed quality improvement package that aims to improve asthma outcomes and reduce asthma's environmental impact by addressing SABA over-use. We investigated the impact of (i) the IIF incentives and (ii) SENTINEL Plus implementation on asthma prescribing. Using Openprescribing.net data, we demonstrate that IIF 2022-2023 had no significant impact on the total number of SABA prescribed in England (25,927,252 during 12-months pre- and 25,885,213 12-months post-IIF; 0.16% decrease; p=NS), but lower carbon footprint SABA inhaler use increased (Salamol™ prescribing increased from 5.1% to 19% of SABA prescriptions, p < 0.01). In contrast, SENTINEL Plus sites significantly reduced SABA prescribing post-implementation (5.43% decrease, p < 0.05).
Collapse
Affiliation(s)
- M G Crooks
- Hull York Medical School, University of Hull, Hull, UK.
- Hull University Teaching Hospitals NHS Trust, Hull, UK.
| | - H Cummings
- Hull University Teaching Hospitals NHS Trust, Hull, UK
| | - A H Morice
- Hull York Medical School, University of Hull, Hull, UK
- Hull University Teaching Hospitals NHS Trust, Hull, UK
| | - D Sykes
- Hull York Medical School, University of Hull, Hull, UK
- Hull University Teaching Hospitals NHS Trust, Hull, UK
| | - S Brooks
- Medical Affairs, AstraZeneca, London, UK
| | - A Jackson
- Medical Affairs, AstraZeneca, London, UK
| | - Y Xu
- Medical Affairs, AstraZeneca, London, UK
| |
Collapse
|
2
|
Brooks S, Zuiker R, Bleys C, Ziagkos D, Moyer JA, van Nueten L, Bonaventure P, Drevets WC, van Gerven J, Salvadore G, Jacobs GE. Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers. J Psychopharmacol 2023:2698811231167989. [PMID: 37165642 DOI: 10.1177/02698811231167989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
BACKGROUND Up to 40% of patients suffering from anxiety disorders do not benefit from currently available pharmacological treatments. Overactivity of the orexin-1 receptor (OX1R) has been implicated in anxiety- and panic-related states. AIM & METHODS We investigated the pharmacokinetics and characterized the pharmacodynamic (PD) profile of the OX1R antagonist JNJ-61393215 using a battery of central nervous system assessments investigating relevant functional domains such as alertness, attention, (visuo)motor coordination, balance, subjective effects and resting-state electroencephalography in a single ascending dose placebo-controlled study in doses from 1 to 90 mg inclusive, assessing PD up to 10 h after dosing, safety and pharmacokinetic in 48 healthy male subjects. RESULTS Average time to maximal plasma concentration (Tmax) ranged between 1.0 and 2.25 h; average half-life ranged from 13.6 to 24.6 h and average maximum plasma concentration ranged from 1.4 to 136.8 ng/mL in the 1 and 90 mg groups, respectively. JNJ-61393215 did not demonstrate any statistically significant or clinically meaningful effects on any PD endpoint at any dose investigated at Tmax nor over the total period up to 10 h post-dose and was well tolerated. The reported somnolence rate was 16.7% (which was attributable to the cohorts receiving 6 mg and higher doses) compared to 12.5% in placebo. CONCLUSION This observation is in line with our knowledge about the OX1R in preclinical studies, where only inconsistent and non-dose-dependent changes in electroencephalography or other behavioural measures were observed under non-challenged conditions, potentially exemplifying the need for a challenged subject.
Collapse
Affiliation(s)
- S Brooks
- Centre for Human Drug Research, Leiden, The Netherlands
- Leiden University Medical Center, Leiden, The Netherlands
| | - Rgja Zuiker
- Centre for Human Drug Research, Leiden, The Netherlands
| | - C Bleys
- Janssen Research & Development, LLC, Beerse, Belgium
| | - D Ziagkos
- Centre for Human Drug Research, Leiden, The Netherlands
| | - J A Moyer
- Janssen Research & Development, LLC, Titusville, NJ, USA
| | - L van Nueten
- Janssen Research & Development, LLC, Beerse, Belgium
| | - P Bonaventure
- Janssen Research & Development, LLC, San Diego, CA, USA
| | - W C Drevets
- Janssen Research & Development, LLC, San Diego, CA, USA
| | - Jma van Gerven
- Centre for Human Drug Research, Leiden, The Netherlands
- Leiden University Medical Center, Leiden, The Netherlands
| | - G Salvadore
- Janssen Research & Development, LLC, Titusville, NJ, USA
| | - G E Jacobs
- Centre for Human Drug Research, Leiden, The Netherlands
- Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
| |
Collapse
|
3
|
Kelly-Quinn M, Biggs JN, Brooks S, Fortuño P, Hegarty S, Jones JI, Regan F. Opportunities, approaches and challenges to the engagement of citizens in filling small water body data gaps. Hydrobiologia 2022; 850:1-21. [PMID: 36065211 PMCID: PMC9430020 DOI: 10.1007/s10750-022-04973-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/24/2022] [Revised: 07/20/2022] [Accepted: 07/22/2022] [Indexed: 06/15/2023]
Abstract
Monitoring the condition (water quality, biodiversity, hydromorphology) of small water bodies presents a challenge for the relevant authorities in terms of time and resources (labour and financial) due to the extensive length of the stream network or the sheer number of small standing water bodies. Citizen science can help address information gaps, but the effort required should not be underestimated if such projects are to generate reliable and sustained data collection. The overall aim of this paper is to propose a framework for operationalisation of citizen science targeting collection of data from small water bodies. We first consider the data gaps and the elements (water chemistry, ecology, hydromorphology) to be addressed, in order to define where citizen science could best make an impact. We review examples of tools and methods that are appropriate for small water bodies, based on experience from a selection of freshwater citizen science projects, and the support that is needed for effective and sustained small water body projects across Europe.
Collapse
Affiliation(s)
- M. Kelly-Quinn
- School of Biology and Environmental Science & UCD Earth Institute, Dublin, Ireland
| | | | - S. Brooks
- Department Life Sciences, Natural History Museum, London, UK
| | - P. Fortuño
- FEHM (Freshwater Ecology, Hydrology and Management), Department of Evolutionary Biology, Ecology and Environmental Sciences, & Institut de Recerca de la Biodiversitat (IRBio), University of Barcelona, Barcelona, Spain
| | - S. Hegarty
- DCU Water Institute, Dublin City University, Dublin, Ireland
| | | | - F. Regan
- DCU Water Institute, Dublin City University, Dublin, Ireland
- School of Chemical Sciences, Dublin City University, Dublin, Dublin, Ireland
| |
Collapse
|
4
|
Overmiller A, Uchiyama A, Hope E, Sawaya A, Nayak S, Hasneen K, Dell'Orso S, Brooks S, Morasso M. 760 Cellular landscape of the skin is primed by the oral epithelial regenerative transcription factor Pitx1 to promote wound healing. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
5
|
Bajpai D, Mehdizadeh S, Uchiyama A, Inoue Y, Sawaya A, Nayak S, Brooks S, Kellett M, Palazzo E, Motegi S, Cataisson C, Morasso M. 088 Deciphering the molecular signals of EGFR pathway activation in Dlx3 deficient skin in cSCC. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Casal Moura M, Deng Z, Brooks S, Tew W, Hummel A, Fervenza F, Kallenberg C, Langford C, Merkel PA, Monach PA, Seo P, Spiera R, St. Clair W, Stone JH, Prunotto M, Grayson P, Specks U. POS0244 ASSOCIATION OF PROTEINASE 3 GENE (PRTN3) Val119Ile POLYMORPHISM (SNP rs351111) WITH RISK OF RELAPSE AMONG HOMOZYGOUS PATIENTS WITH PR3 ANCA-ASSOCIATED VASCULITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.4977] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundThe frequency of the proteinase 3 gene (PRTN3) polymorphisms in patients with ANCA-associated vasculitis (AAV) is not well characterized. We hypothesize that PRTN3 gene polymorphisms induce allosteric changes in PR3 conformation which may alter its interaction with ligands and PR3-ANCA during inflammation with potential implications for disease presentation and clinical outcomes.ObjectivesTo analyze the association of PRTN3 Val119Ile polymorphism (SNP rs351111) with risk of relapse risk among homozygous patients with PR3 ANCA-associated vasculitis.MethodsDNA variant calling for SNP rs351111 (chr.19:844020, c.355G>A) in PRTN3 gene assessed the allelic frequency in patients with PR3-AAV included in the Rituximab versus Cyclophosphamide (RAVE) trial. This was followed by RNA-seq variant calling to characterize the mRNA expression. We compared clinical presentation and outcomes between patients homozygous for PR3-Ile119 or PR3-Val119.ResultsSerum samples for DNA calling were available in 188 of the 197 patients with AAV in the RAVE cohort. 75 PR3-AAV patients had the allelic variant: 13 patients were homozygous for PR3-Ile119 and 62 patients were heterozygous PR3-Val119Ile with an allele frequency threshold of 29.3 – 55.1% of reads (Figure 1A and 1B). RNA-seq was available for 89 patients and the mRNA corresponding to the allelic variant was found in 35 PR3-AAV patients: 13 patients were homozygous for PR3-Ile119 and 22 patients were heterozygous PR3-Val119Ile with an allele frequency threshold of 11.1 – 62.8% of reads (Figure 1A and 1C). The agreement between the DNA calling results and the mRNA expression of the 86 patients that overlapped was 100%. We found an additional homozygous patient for PR3-Val119 in which blood was not available for DNA calling. We compared the clinical presentation and outcomes of 74 patients with PR3-AAV: 13 homozygous for PR3-Ile119 and 51 homozygous for PR3-Val119 (Table 1). The frequency of severe flares at 18 months in homozygous PR3-Ile119 was ≥ 2x higher when compared with homozygous PR3-Val119 (46.2% vs. 19.6%, p=0.048). We found no differences in clinical presentation.Figure 1.RAVE trial population distribution according to the zygosity status for PRTN3 gene (PR3 and MPO-ANCA patients) and DNA or RNA variant calling (panel A). Allelic frequency for rs351111, chr.19:844020 (c.355G>A) in PRTN3 among patients with AAV (PR3 and MPO-ANCA) in the DNA (panel B) and RNA (panel C) variant calling.Table 1.Outcomes of patients with PR3-ANCA according with PRTN3 zygosity.PR3-ANCA (n=64)Homozygous PR3-Val119(n=51)HomozygousPR3-Ile119(n=13)p-value Remission, n (%)45 (88.2)13 (100)0.194 Complete remission, n (%)36 (70.6)10 (76.9)0.650 Any flare 18 months, n (%)30 (58.8)7 (53.8)0.746 Severe Relapse* 18 months, n (%)10 (19.6)6 (46.2)0.048* Relapse was considered “Severe” if Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis (BVAS/WG) > 3 or one major item as per the RAVE trial definition.Abbreviations: ANCA - anti-neutrophil cytoplasmic antibody; Ile – isoleucine; n- number; PR3 - proteinase 3; Val - valine.ConclusionIn patients with PR3-AAV the presence of PRTN3 Val119Ile polymorphism was associated with higher frequency of severe relapse. Further studies are necessary to understand the association of this observation with the risk of severe relapse.References[1]Stone JH et al N Engl J Med 2010; 363:221-232Disclosure of InterestsNone declared
Collapse
|
7
|
Wortman B, Post C, Powell M, Khaw P, Fyles A, D’Amico R, Haie-Meder C, Jurgenliemk-Schulz I, McCormack M, Do V, Katsaros D, Bessette P, Baron M, Nout R, Whitmarsh K, Mileshkin L, Lutgens L, Kitchener H, Brooks S, Nijman H, Astreinidou E, Putter H, Creutzberg C, de Boer S. OC-0298 Toxicity and patient-reported symptoms after 3D-conformal or intensity-modulated pelvic radiotherapy. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06845-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Brooks S, Harper A, Pack L, Wheatley T. 460 THE IMPACT OF THE BONE MDT: EXPLORING CHANGES IN BONE PROTECTION DECISIONS BETWEEN 2015 AND 2018. Age Ageing 2021. [DOI: 10.1093/ageing/afab116.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
The Hip fracture Multidisciplinary metabolic bone Team (MDT) was developed in June 2016 as a collaboration between Orthogeriatricians and the Metabolic Bone Team. The objective was to improve the quality of bone protection treatment decisions. This audit aimed to assess the impact of the new MDT by reviewing treatment decisions prior to and post its introduction. Data collection and.
Methodology
Case notes were reviewed for admissions from September to October 2015 and from September to November 2018. For both time periods the inpatient list, discharge summary and blood tests were reviewed in order to collect data regarding demographics, type of surgery, co-morbidities, calcium and vitamin D levels, bone protection prior to admission and bone protection decisions at discharge.
Results
In 2015, 83% of patients were admitted with no form of bone protection. Around 6% of patients were admitted on a bisphosphonate and 36% were discharged on a bisphosphonate. Less than 2% of people received denosumab prior to their admission, with this number rising to 9.4% at discharge. In 2018, 77% of patients were admitted on no form of bone protection. 5.4% were admitted on a bisphosphonate rising to 16% on discharge. No patients were admitted on denosumab, but 27% were discharged having received it in hospital, or with a plan to receive it from their GP.
Conclusions
There was a fall in bisphosphonate use and a significant increase in the frequency of denosumab prescription after the introduction of the Bone MDT. This MDT facilitated better decision-making through access to the further specialist skills from the endocrinologist and specialist nurses. Individual case discussion enhanced the delivery of personalised medicine.
Collapse
Affiliation(s)
- S Brooks
- Princess Royal Hospital, Haywards Heath
| | - A Harper
- Princess Royal Hospital, Haywards Heath
| | - L Pack
- Princess Royal Hospital, Haywards Heath
| | | |
Collapse
|
9
|
Croitoru D, Sibbald C, Alavi A, Brooks S, Piguet V. Challenging the association of hepatitis C and pyoderma gangrenosum. Br J Dermatol 2021; 185:1047-1048. [PMID: 34105770 DOI: 10.1111/bjd.20566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 06/02/2021] [Accepted: 06/07/2021] [Indexed: 11/30/2022]
Affiliation(s)
- D Croitoru
- Faculty of Medicine, University of Toronto, Toronto, Canada.,Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada
| | - C Sibbald
- Faculty of Medicine, University of Toronto, Toronto, Canada.,Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.,Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Canada.,Hospital for Sick Children, Section␣of Dermatology, Toronto, Canada
| | - A Alavi
- Department of Dermatology, Mayo Clinic, Rochester, MN, USA
| | - S Brooks
- Faculty of Medicine, University of Toronto, Toronto, Canada
| | - V Piguet
- Faculty of Medicine, University of Toronto, Toronto, Canada.,Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.,Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Canada
| |
Collapse
|
10
|
Homburg R, Rao U, Malamas F, Palouki P, Gudi A, Shah A, Brooks S, Drakeley A, Faye S. Automated anti-Mullerian hormone measurement: data review to provide insights and interpretation. Gynecol Endocrinol 2021; 37:511-514. [PMID: 32603200 DOI: 10.1080/09513590.2020.1785419] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Abstract
RESULTS AMH results were pooled and a table with 2.5 and 97.5 percentiles for each age group constructed. Based on Youden index, the optimal cut off for low responders (0-3 eggs), was 5.5 pmol/l (87% sensitivity, 55% specificity) and for high responders (>15 eggs) 15.6 pmol/l (78% sensitivity, 57% specificity). AMH correlated with number of eggs collected (r = 0.48) and clinical pregnancies (r = 0.14), (p < .0001). CONCLUSIONS The table of AMH levels measured using the Access 2 fully automated immunoassay system according to age may be used as a reference and cutoff levels for high and poor responders are clearly defined to help tailor controlled ovarian stimulation, maximizing efficiency and ensuring patient safety. The use of a random access automated immunoassay system means that blood sampled on arrival can produce an AMH result in 40 mins by the time the subject enters the doctor's clinic together with other relevant endocrine markers.
Collapse
Affiliation(s)
- R Homburg
- Homerton Fertility Centre, Homerton University NHS Foundation Trust Hospital, London, UK
| | - U Rao
- Homerton Fertility Centre, Homerton University NHS Foundation Trust Hospital, London, UK
| | - F Malamas
- Homerton Fertility Centre, Homerton University NHS Foundation Trust Hospital, London, UK
| | - P Palouki
- Homerton Fertility Centre, Homerton University NHS Foundation Trust Hospital, London, UK
| | - A Gudi
- Homerton Fertility Centre, Homerton University NHS Foundation Trust Hospital, London, UK
| | - A Shah
- Homerton Fertility Centre, Homerton University NHS Foundation Trust Hospital, London, UK
| | - S Brooks
- Hewitt Fertility Centre, Liverpool Women's Hospital, Liverpool, UK
| | - A Drakeley
- Hewitt Fertility Centre, Liverpool Women's Hospital, Liverpool, UK
| | - S Faye
- Independent Scientific Consultant, Leeds, UK
| |
Collapse
|
11
|
Brooks S, Zuiker RGJA, Jacobs GE, Kezic I, Savitz A, Van Der Ark PD, Van Gerven JMA. 341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration. Sleep 2021. [DOI: 10.1093/sleep/zsab072.340] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Seltorexant (JNJ-42847922), a potent and selective antagonist of the human orexin-2 receptor, is being developed for the treatment of major depressive disorder. Seltorexant also has sleep-promoting properties. Investigating the effects of sleep-promoting medications on driving is important because some of these agents (e.g. GABAA receptor agonists) may be associated with increased risk of motor vehicle accidents. We evaluated the effect of seltorexant on driving after forced awakening at night, using a validated driving simulator.
Methods
This double-blind, placebo and active-controlled, randomized, 3-way cross-over study was conducted in 18 male and 18 female healthy subjects. All subjects received seltorexant 40 mg, zolpidem 10 mg, or placebo 15 minutes before bedtime. Eighteen subjects were awakened at 2- and 6-hours post-dose, and the other 18 at 4- and 8-hours post-dose. At those timepoints, pharmacokinetics, objective (standard deviation of the lateral position [SDLP]) and subjective effects (using Perceived Driving Quality and Effort Scales) on driving ability, postural stability and subjective sleepiness were assessed.
Results
For seltorexant, the SDLP difference from placebo (95% confidence interval) at 2-, 4-, 6- and 8-hours post-dose was 3.9 cm (1.26, 6.60), 0.9 cm (-1.08, 2.92), 1.1 cm (-0.42, 2.63), and 0.6 cm (-2.75, 1.55), respectively vs. 9.6 cm (6.97, 12.38), 6.6 cm (3.53, 9.60), 4.7 cm (1.46, 7.85), and 1.3cm (-1.16, 3.80), respectively for zolpidem. The difference from placebo was significant at 2-hours after taking seltorexant, while the difference from placebo was significant at 2, 4 and 6-hours after zolpidem. Subjective driving quality was decreased for both drugs at all time points and driving effort was increased up to 4-hours post-dose for both medications. Subjective sleepiness showed a significant increase compared to placebo 2- and 4-hours after administration of either drug. Postural stability was decreased up to 2-hours after administration of seltorexant, and up to 4-hours after administration of zolpidem.
Conclusion
Compared to zolpidem, objective effects on driving performance were more transient after seltorexant administration and largely normalized by 4–6 hours post-dose.
Support (if any)
This work was sponsored by Janssen R&D.
Collapse
|
12
|
Powell B, Horvath K, Wickens C, Miller-Cushon E, Keil A, Brooks S. 35 Refined phenotyping methods for the equine cardiac startle response. J Equine Vet Sci 2021. [DOI: 10.1016/j.jevs.2021.103498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Overmiller A, Uchiyama A, Hope E, Grassini D, Sawaya A, Nayak S, Hasneen K, Chen Y, Brooks S, Morasso M. 611 Oral epithelial regenerative transcription factor Pitx1 reprograms keratinocytes to promote cutaneous wound healing. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
14
|
Metz S, Brooks S. Process Implementation to Improve Vaccination Rates in Solid Organ Transplant Candidates. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
15
|
Post C, De Boer S, Powell M, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger P, Ledermann J, Khaw P, D'Amico R, Fyles A, Baron M, Kitchener H, Nijman H, Lutgens L, Brooks S, Jürgenliemk-Schulz I, Feeney A, Nout R, Verhoeven-Adema K, Smit V, Putter H, Creutzberg C. OC-0369: Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00393-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
16
|
Bartnik A, Banerjee N, Burke D, Crittenden J, Deitrick K, Dobbins J, Gulliford C, Hoffstaetter GH, Li Y, Lou W, Quigley P, Sagan D, Smolenski K, Berg JS, Brooks S, Hulsart R, Mahler G, Meot F, Michnoff R, Peggs S, Roser T, Trbojevic D, Tsoupas N, Miyajima T. CBETA: First Multipass Superconducting Linear Accelerator with Energy Recovery. Phys Rev Lett 2020; 125:044803. [PMID: 32794783 DOI: 10.1103/physrevlett.125.044803] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 06/09/2020] [Indexed: 06/11/2023]
Abstract
Energy recovery has been achieved in a multipass linear accelerator, demonstrating a technology for more compact particle accelerators operating at higher currents and reduced energy consumption. Energy delivered to the beam during the first four passes through the accelerating structure was recovered during four subsequent decelerating passes. High-energy efficiency was achieved by the use of superconducting accelerating cavities and permanent magnets. The fixed-field alternating-gradient optical system used for the return loop successfully transported electron bunches of 42, 78, 114, and 150 MeV in a common vacuum chamber. This new kind of accelerator, an eight-pass energy recovery linac, has the potential to accelerate much higher current than existing linear accelerators while maintaining small beam dimensions and consuming much less energy per electron.
Collapse
Affiliation(s)
- A Bartnik
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - N Banerjee
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - D Burke
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - J Crittenden
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - K Deitrick
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - J Dobbins
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - C Gulliford
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - G H Hoffstaetter
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - Y Li
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - W Lou
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - P Quigley
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - D Sagan
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - K Smolenski
- Cornell Laboratory for Accelerator Based Sciences and Education, Cornell University, Ithaca, New York 14850, USA
| | - J S Berg
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Brooks
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R Hulsart
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - G Mahler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - F Meot
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - R Michnoff
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - S Peggs
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Roser
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - D Trbojevic
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - N Tsoupas
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | - T Miyajima
- High Energy Accelerator Research Organization (KEK), Oho, Tsukuba, Ibaraki 305-0801, Japan
| |
Collapse
|
17
|
Mellion M, Ronco L, Thompson D, Hage M, Brooks S, van Brummelen E, Pagan L, Badrising U, Van Engelen B, Groeneveld G, Cadavid D. O.25Phase 1 clinical trial of losmapimod in FSHD: safety, tolerability and target engagement. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
18
|
Jones M, Sergeant C, Richardson M, Groth D, Brooks S, Munyard K. A non-synonymous SNP in exon 3 of the KIT gene is responsible for the classic grey phenotype in alpacas (Vicugna pacos). Anim Genet 2019; 50:493-500. [PMID: 31297861 DOI: 10.1111/age.12814] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2019] [Indexed: 11/30/2022]
Abstract
The alpaca classic grey phenotype is of particular interest to the industry. Until now, there were only indirect data suggesting that the KIT gene was involved in the classic grey phenotype. All exons of KIT in three black and three classic silvergrey alpacas were sequenced. Five non-synonymous SNPs were observed. There was only one SNP found that was present only in the silvergrey alpacas, and this was also the only SNP predicted to be damaging. This variant results in a change of a glycine (Gly) to an arginine (Arg) at amino acid position 126 (c.376G>A), occurring in the second Ig-like domain of the extracellular domain of KIT. Basic protein modelling predicted that this variant is likely destabilising. Therefore, an additional 488 alpacas were genotyped for this SNP using the tetra-primer amplification refractory mutation system PCR (Tetra-primer ARMS-PCR). All classic grey alpacas were observed to be heterozygous, and 99.3% of non-grey dark base colour alpacas were found to be homozygous for the wildtype allele in this position. These results confirm that the classic grey phenotype in alpacas is the result of a c.376G>A (p.Gly126Arg) SNP in exon 3 of KIT. These data also support the hypothesis that the grey phenotype is autosomal dominant and that the mutation is most likely homozygous lethal.
Collapse
Affiliation(s)
- M Jones
- CHIRI Biosciences, School of Pharmacy and Biomedical Sciences, Curtin University, Perth, 6845, WA, Australia
| | - C Sergeant
- CHIRI Biosciences, School of Pharmacy and Biomedical Sciences, Curtin University, Perth, 6845, WA, Australia
| | - M Richardson
- Genomics Research and Discovery Facility, School of Life and Environmental Sciences, Deakin University, Geelong, 3220, Vic., Australia
| | - D Groth
- CHIRI Biosciences, School of Pharmacy and Biomedical Sciences, Curtin University, Perth, 6845, WA, Australia
| | - S Brooks
- Department of Animal Science, UF Genetics Institute, University of Florida, Gainesville, FL, 32610, USA
| | - K Munyard
- CHIRI Biosciences, School of Pharmacy and Biomedical Sciences, Curtin University, Perth, 6845, WA, Australia
| |
Collapse
|
19
|
Patterson-Rosa L, Wickens C, Brooks S. Bringing horse genetics to owners and industry professionals through online extension. J Equine Vet Sci 2019. [DOI: 10.1016/j.jevs.2019.03.180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Cho R, Brooks S, Fahmy M, Campbell J. Reduction of postoperative narcotic usage following mandibular orthognathic surgery: efficacy of liposomal bupivicaine examine. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
21
|
Nayak S, Cross M, Brooks S, Bible P, Jiang K, Dell'Orso S, Gutierrez-Cruz G, Naz F, Sun H, Morasso M. 312 Epigenetic modules governing skin epidermal homeostasis. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
22
|
Uchiyama A, Nayak S, Nayak S, Cross M, Overmiller A, Grassini D, Sawaya A, Gutkind J, Brooks S, Morasso M. 930 SOX2 epidermal overexpression promotes cutaneous wound healing via activation of EGFR/MEK/ERK signaling mediated by EGFR ligands. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.1006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Hashim H, Lane A, Worthington J, Noble S, Brooks S, Cotterill N, Page T, Swami S, Abrams P. Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate: Results of the UNBLOCS randomized controlled trial. ACTA ACUST UNITED AC 2019. [DOI: 10.1016/s1569-9056(19)30935-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
24
|
Kottmaier M, Bourier F, Wünscher S, Kornmayer M, Semmler V, Lengauer S, Telishevska M, Koch-Büttner K, Risse E, Brooks S, Hessling G, Deisenhofer I, Reents T. Repeat ablation for paroxysmal atrial fibrillation - Does adenosine play a role in predicting pulmonary vein reconnection patterns? Indian Pacing Electrophysiol J 2018; 18:203-207. [PMID: 30290206 PMCID: PMC6302775 DOI: 10.1016/j.ipej.2018.09.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2018] [Revised: 09/05/2018] [Accepted: 09/27/2018] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Pulmonary vein (PV) reconduction after PV isolation (PVI) unmasked by adenosine is associated with a higher risk for paroxysmal atrial fibrillation (PAF) recurrence. It is unknown if the reconnected PVs after adenosine testing and immediate re-ablation can predict reconnection and reconnection patterns of PVs at repeat procedures. We assessed reconnection of PVs with and without dormant-conduction (DC) during the first and the repeat procedure. METHODS We included 67 patients undergoing PVI for PAF and a second procedure for PAF recurrence. DC during adenosine administration at first procedure was seen in 31 patients (46%). 264 PVs were tested with adenosine; DC was found in 48 PVs (18%) and re-ablated during first procedure. During the second procedure, all PVs where checked for reconnection. RESULTS Fifty-eight patients (87%) showed PV reconnection during the second procedure. Reconnection was found in 152/264 PVs (58%). Of 216 PVs without reconnection during adenosine testing at the first ablation, 116 PVs (53.7%) showed reconnection at the repeat procedure. Overall, 14.9% of patients showed the same PV reconnection pattern in the first and second procedure, expected statistical probability of encountering the same reconnection pattern was only 6.6%(p = 0.012). CONCLUSIONS In repeat procedures PVs showed significantly more often the same reconnection pattern as during first procedure than statistically expected. More than 50% of initial isolated PVs without reconnection during adenosine testing showed a reconnection during repeat ablation. Techniques to detect susceptibility for PV re-connection like prolonged waiting-period should be applied. Elimination of DC should be expanded from segmental to circumferential re-isolation or vaster RF application.
Collapse
Affiliation(s)
- M Kottmaier
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany.
| | - F Bourier
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - S Wünscher
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - M Kornmayer
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - V Semmler
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - S Lengauer
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - M Telishevska
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - K Koch-Büttner
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - E Risse
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - S Brooks
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - G Hessling
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - I Deisenhofer
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| | - T Reents
- Department of Electrophysiology, German Heart Center Munich, Technische Universitaet Munich, Germany
| |
Collapse
|
25
|
Bourier F, Hofmann M, Kathan A, Reents T, Zeilberger M, Pracht L, Kottmaier M, Risse E, Brooks S, Koch-Buttner K, Telishevska M, Lengauer S, Kornmayr ML, Hessling G, Deisenhofer I. P3834Early recurrence of atrial fibrillation after pulmonary vein isolation is associated with poor outcome. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- F Bourier
- Technical University of Munich, German Heart Center, Munich, Germany
| | - M Hofmann
- Technical University of Munich, German Heart Center, Munich, Germany
| | - A Kathan
- Technical University of Munich, German Heart Center, Munich, Germany
| | - T Reents
- Technical University of Munich, German Heart Center, Munich, Germany
| | - M Zeilberger
- Technical University of Munich, German Heart Center, Munich, Germany
| | - L Pracht
- Technical University of Munich, German Heart Center, Munich, Germany
| | - M Kottmaier
- Technical University of Munich, German Heart Center, Munich, Germany
| | - E Risse
- Technical University of Munich, German Heart Center, Munich, Germany
| | - S Brooks
- Technical University of Munich, German Heart Center, Munich, Germany
| | - K Koch-Buttner
- Technical University of Munich, German Heart Center, Munich, Germany
| | - M Telishevska
- Technical University of Munich, German Heart Center, Munich, Germany
| | - S Lengauer
- Technical University of Munich, German Heart Center, Munich, Germany
| | - M L Kornmayr
- Technical University of Munich, German Heart Center, Munich, Germany
| | - G Hessling
- Technical University of Munich, German Heart Center, Munich, Germany
| | - I Deisenhofer
- Technical University of Munich, German Heart Center, Munich, Germany
| |
Collapse
|
26
|
Kottmaier M, Reents T, Bourier F, Reiter A, Semmler V, Telishevska M, Berger F, Koch-Buettner K, Brooks S, Kornmayer M, Risse E, Lengauer S, Hessling G, Deisenhofer I. P5757Mapping and ablation of complex left atrial tachycardia using an automated high resolution mapping algorithm. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Kottmaier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - T Reents
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Bourier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - A Reiter
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - V Semmler
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Telishevska
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Berger
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - K Koch-Buettner
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Brooks
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Kornmayer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - E Risse
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Lengauer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - G Hessling
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - I Deisenhofer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| |
Collapse
|
27
|
Kottmaier M, Mayer S, Bourier F, Reents T, Semmler V, Telishevska M, Kornmayer M, Brooks S, Lengauer S, Berger F, Koch-Buettner K, Risse E, Hessling G, Deisenhofer I, Holdenrieder S. P989Association between circulating biomarkers of fibrosis and left atrial voltage in patients undergoing atrial fibrillation ablation. A pilot study. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- M Kottmaier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Mayer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Bourier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - T Reents
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - V Semmler
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Telishevska
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Kornmayer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Brooks
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Lengauer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Berger
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - K Koch-Buettner
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - E Risse
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - G Hessling
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - I Deisenhofer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Holdenrieder
- German Heart Center of Munich, Institut of Laboratory Medicine, Munich, Germany
| |
Collapse
|
28
|
Muehlan C, Brooks S, Zuiker R, van Gerven J, Dingemanse J. 0007 Multiple-Ascending-Dose Study Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, And Tolerability. Sleep 2018. [DOI: 10.1093/sleep/zsy061.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- C Muehlan
- Idorsia Pharmaceuticals Ltd, Allschwil, SWITZERL
| | - S Brooks
- Centre for Human Drug Research (CHDR), Leiden, NETHERLANDS
| | - R Zuiker
- Centre for Human Drug Research (CHDR), Leiden, NETHERLANDS
| | - J van Gerven
- Centre for Human Drug Research (CHDR), Leiden, NETHERLANDS
| | - J Dingemanse
- Idorsia Pharmaceuticals Ltd, Allschwil, SWITZERL
| |
Collapse
|
29
|
Muehlan C, Brooks S, Zuiker R, van Gerven J, Dingemanse J. 0008 Night-Time Administration Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Pharmacokinetics, Next-Day Residual Effects, Safety, And Tolerability. Sleep 2018. [DOI: 10.1093/sleep/zsy061.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C Muehlan
- Idorsia Pharmaceuticals Ltd, Allschwil, SWITZERL
| | - S Brooks
- Centre for Human Drug Research (CHDR), Leiden, NETHERLANDS
| | - R Zuiker
- Centre for Human Drug Research (CHDR), Leiden, NETHERLANDS
| | - J van Gerven
- Centre for Human Drug Research (CHDR), Leiden, NETHERLANDS
| | - J Dingemanse
- Idorsia Pharmaceuticals Ltd, Allschwil, SWITZERL
- Idorsia Pharmaceuticals Ltd, Allschwil, SWITZERL
| |
Collapse
|
30
|
Von Krogh F, Semmler V, Reents T, Bourier F, Telishevska M, Kornmayer M, Kottmaier M, Brooks S, Koch-Buettner K, Lennerz C, Brkic A, Grebmer C, Hessling G, Kolb C, Deisenhofer I. P843Incidence of acute pacemaker implantation after ablation of persistent atrial fibrillation. Europace 2018. [DOI: 10.1093/europace/euy015.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- F Von Krogh
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - V Semmler
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - T Reents
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - F Bourier
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - M Telishevska
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - M Kornmayer
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - M Kottmaier
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - S Brooks
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - K Koch-Buettner
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - C Lennerz
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - A Brkic
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - C Grebmer
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - G Hessling
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - C Kolb
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| | - I Deisenhofer
- German Heart Center, Clinic for Heart and Circulatory Diseases, Munich, Germany
| |
Collapse
|
31
|
Kottmaier M, Bourier F, Pausch H, Reents T, Semmler V, Telishevska M, Koch-Buettner K, Lengauer S, Brooks S, Kornmayer M, Berger F, Rousseva E, Kolb C, Hessling G, Deisenhofer I. P379Safety of uninterrupted periprocedural edoxaban versus phenprocoumon for patients undergoing left atrial catheter ablation procedures. Europace 2018. [DOI: 10.1093/europace/euy015.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Kottmaier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Bourier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - H Pausch
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - T Reents
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - V Semmler
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Telishevska
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - K Koch-Buettner
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Lengauer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Brooks
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Kornmayer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Berger
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - E Rousseva
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - C Kolb
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - G Hessling
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - I Deisenhofer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| |
Collapse
|
32
|
Kottmaier M, Bourier F, Reents T, Berglar S, Semmler V, Jilek C, Kornmayer M, Telishevksa M, Lengauer S, Brooks S, Berger F, Koch-Buettner K, Hadamitzky M, Hessling G, Deisenhofer I. 204Exclusion of left atrial thrombus by dual source cardiac computed tomography prior to catheter ablation for atrial fibrillation. Europace 2018. [DOI: 10.1093/europace/euy015.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- M Kottmaier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Bourier
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - T Reents
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Berglar
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - V Semmler
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - C Jilek
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Kornmayer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Telishevksa
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Lengauer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - S Brooks
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - F Berger
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - K Koch-Buettner
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - M Hadamitzky
- German Heart Center of Munich, Radiology, Munich, Germany
| | - G Hessling
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| | - I Deisenhofer
- German Heart Center of Munich, Department of Electrophysiology, Munich, Germany
| |
Collapse
|
33
|
Kelly E, Martin PAJ, Gibson-Kueh S, Morgan DL, Ebner BC, Donaldson J, Buller N, Crook DA, Brooks S, Davis AM, Hammer MP, Foyle L, Hair S, Lymbery AJ. First detection of Edwardsiella ictaluri (Proteobacteria: Enterobacteriaceae) in wild Australian catfish. J Fish Dis 2018; 41:199-208. [PMID: 28836666 DOI: 10.1111/jfd.12696] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Revised: 06/28/2017] [Accepted: 06/30/2017] [Indexed: 06/07/2023]
Abstract
The bacterium Edwardsiella ictaluri is considered to be one of the most significant pathogens of farmed catfish in the United States of America and has also caused mortalities in farmed and wild fishes in many other parts of the world. E. ictaluri is not believed to be present in wild fish populations in Australia, although it has previously been detected in imported ornamental fishes held in quarantine facilities. In an attempt to confirm freedom from the bacterium in Australian native fishes, we undertook a risk-based survey of wild catfishes from 15 sites across northern Australia. E. ictaluri was detected by selective culturing, followed by DNA testing, in Wet Tropics tandan (Tandanus tropicanus) from the Tully River, at a prevalence of 0.40 (95% CI 0.21-0.61). The bacterium was not found in fishes sampled from any of the other 14 sites. This is the first report of E. ictaluri in wild fishes in Australia.
Collapse
Affiliation(s)
- E Kelly
- Freshwater Fish Group & Fish Health Unit, Centre for Fish & Fisheries Research, School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia
| | - P A J Martin
- Freshwater Fish Group & Fish Health Unit, Centre for Fish & Fisheries Research, School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia
| | - S Gibson-Kueh
- Freshwater Fish Group & Fish Health Unit, Centre for Fish & Fisheries Research, School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia
| | - D L Morgan
- Freshwater Fish Group & Fish Health Unit, Centre for Fish & Fisheries Research, School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia
| | - B C Ebner
- Freshwater Fish Group & Fish Health Unit, Centre for Fish & Fisheries Research, School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia
- TropWATER, James Cook University, Townsville, Qld, Australia
- CSIRO Land & Water, Atherton, Qld, Australia
| | - J Donaldson
- TropWATER, James Cook University, Townsville, Qld, Australia
- CSIRO Land & Water, Atherton, Qld, Australia
| | - N Buller
- Animal Health Laboratories, Department of Agriculture and Food of Western Australia, South Perth, WA, Australia
| | - D A Crook
- Research Institute for the Environment and Livelihoods, Charles Darwin University, Casuarina, NT, Australia
| | - S Brooks
- Queensland Department of Agriculture and Fisheries, Brisbane, Qld, Australia
| | - A M Davis
- TropWATER, James Cook University, Townsville, Qld, Australia
- CSIRO Land & Water, Atherton, Qld, Australia
| | - M P Hammer
- Museum and Art Gallery of the Northern Territory, Darwin, NT, Australia
| | - L Foyle
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Qld, Australia
| | - S Hair
- Animal Health Laboratories, Department of Agriculture and Food of Western Australia, South Perth, WA, Australia
| | - A J Lymbery
- Freshwater Fish Group & Fish Health Unit, Centre for Fish & Fisheries Research, School of Veterinary and Life Sciences, Murdoch University, Perth, WA, Australia
| |
Collapse
|
34
|
Koch-Buettner K, Kottmaier M, Reents T, Holmgren E, Semmler V, Deiss M, Telishevska M, Kornmayer M, Brooks S, Grebmer C, Lennerz K, Kolb C, Hessling G, Deisenhofer I. P202Identification of predictors for atrial fibrillation-free survival after catheter ablation of persistent atrial fibrillation-results from a large prospective cohort. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
35
|
Staiger EA, Almén MS, Promerová M, Brooks S, Cothran EG, Imsland F, Jäderkvist Fegraeus K, Lindgren G, Mehrabani Yeganeh H, Mikko S, Vega-Pla JL, Tozaki T, Rubin CJ, Andersson L. The evolutionary history of theDMRT3‘Gait keeper’ haplotype. Anim Genet 2017; 48:551-559. [DOI: 10.1111/age.12580] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/25/2017] [Indexed: 01/25/2023]
Affiliation(s)
- E. A. Staiger
- Department of Medical Biochemistry and Microbiology; Uppsala University; SE-75123 Uppsala Sweden
| | - M. S. Almén
- Department of Medical Biochemistry and Microbiology; Uppsala University; SE-75123 Uppsala Sweden
| | - M. Promerová
- Department of Medical Biochemistry and Microbiology; Uppsala University; SE-75123 Uppsala Sweden
| | - S. Brooks
- Department of Animal Science; University of Florida; Gainesville FL 32611-0910 USA
| | - E. G. Cothran
- Department of Veterinary Integrative Biosciences; College of Veterinary Medicine and Biomedical Sciences; Texas A&M University; College Station TX 77843-4458 USA
| | - F. Imsland
- Department of Medical Biochemistry and Microbiology; Uppsala University; SE-75123 Uppsala Sweden
| | - K. Jäderkvist Fegraeus
- Department of Animal Breeding and Genetics; Swedish University of Agricultural Sciences; SE-75007 Uppsala Sweden
| | - G. Lindgren
- Department of Animal Breeding and Genetics; Swedish University of Agricultural Sciences; SE-75007 Uppsala Sweden
| | | | - S. Mikko
- Department of Animal Breeding and Genetics; Swedish University of Agricultural Sciences; SE-75007 Uppsala Sweden
| | - J. L. Vega-Pla
- Laboratorio de Investigación Aplicada; Cría Caballar de las Fuerzas Armadas; 14080 Cordoba Spain
| | - T. Tozaki
- Genetic Analysis Department; Laboratory of Racing Chemistry; Tochigi 320-0851 Utsunomiya Japan
| | - C. J. Rubin
- Department of Medical Biochemistry and Microbiology; Uppsala University; SE-75123 Uppsala Sweden
| | - L. Andersson
- Department of Medical Biochemistry and Microbiology; Uppsala University; SE-75123 Uppsala Sweden
- Department of Veterinary Integrative Biosciences; College of Veterinary Medicine and Biomedical Sciences; Texas A&M University; College Station TX 77843-4458 USA
- Department of Animal Breeding and Genetics; Swedish University of Agricultural Sciences; SE-75007 Uppsala Sweden
| |
Collapse
|
36
|
Koch-Buettner K, Kottmaier M, Reents T, Semmler V, Holmgren E, Deiss M, Telishevska M, Kornmayer M, Brooks S, Grebmer C, Lennerz K, Kolb C, Hessling G, Deisenhofer I. P894Identification of predictors for atrial fibrillation-free survival after catheter ablation of persistent atrial fibrillation-results from a large prospective cohort. Europace 2017. [DOI: 10.1093/ehjci/eux151.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
37
|
Rousseva E, Hofmann M, Koch Buettner K, Bourier F, Kottmaier M, Kornmayer M, Brooks S, Kathan S, Lennerz C, Grebmer C, Brikic A, Deiss M, Kolb C, Hessling G, Deisenhofer I. P274Occurrence of persistent atrial fibrillation after pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 2017. [DOI: 10.1093/ehjci/eux141.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Bourier F, Reents T, Semmler V, Brooks S, Kornmayer M, Kottmaier M, Telishevska M, Deiss M, Hessling G, Deisenhofer I. P332Very low dose fluoroscopic imaging for electrophysiology procedures. Europace 2017. [DOI: 10.1093/ehjci/eux141.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Deiss M, Rousseva E, Bourier F, Kottmaier M, Brkic A, Semmler V, Telishevska M, Koch-Buettner K, Brooks S, Kornmayer M, Lengauer S, Berger F, Hessling G, Deisenhofer I, Reents T. P939Catheter ablation of atrial flutter: (typical) right atrial and (atypical) left atrial flutter occur in similar patients but have different outcome of ablation. Europace 2017. [DOI: 10.1093/ehjci/eux151.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Bourier F, Reents T, Semmler V, Telishevska M, Brooks S, Kornmayer M, Kottmaier M, Hessling G, Deisenhofer I. P333Transseptal puncture guided by CT-derived 3D-augmented fluoroscopy. Europace 2017. [DOI: 10.1093/ehjci/eux141.060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Kottmaier M, Reents T, Bourier F, Semmler V, Telishevska M, Deiss M, Koch-Buettner K, Lengauer S, Kornmayer M, Brooks S, Rousseva E, Hessling G, Deisenhofer I. P864Reconnection patterns of pulmonary veins during a repeat paroxysmal atrial fibrillation ablation. Europace 2017. [DOI: 10.1093/ehjci/eux151.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Kottmaier M, Reents T, Bourier F, Semmler V, Telishevska M, Deiss M, Koch-Buettner K, Lengauer S, Kornmayer M, Brooks S, Rousseva E, Hessling G, Deisenhofer I. P891Persistent atrial fibrillation ablation: What are the predictors for intraprocedural AF termination? Europace 2017. [DOI: 10.1093/ehjci/eux151.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
43
|
Bourier F, Reents T, Telishevska M, Kottmaier M, Semmler V, Kornmayer M, Brooks S, Deisenhofer I, Hessling G. P927Atrial fibrillation after atrial septal defect device closure - How to access the left atrium? A case series. Europace 2017. [DOI: 10.1093/ehjci/eux151.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
44
|
Kornmayer M, Brooks S, Semmler V, Telishevska M, Bourier F, Kochbuettner K, Kottmair M, Lengauer S, Rousseva E, Lennerz C, Grebmer C, Reents T, Kolb C, Hessling G, Deisenhofer I. P875Is atrial anatomy predictive for paroxysmal AF recurrence after PVI? Europace 2017. [DOI: 10.1093/ehjci/eux151.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Kottmaier M, Oesterlein T, Reents T, Bourier F, Reiter A, Semmler V, Telishevska M, Deiss M, Koch-Buettner K, Lengauer S, Brooks S, Rousseva E, Kornmayer M, Hessling G, Deisenhofer I. P863How reliable are left atrial voltage maps assessed during atrial fibrillation. Europace 2017. [DOI: 10.1093/ehjci/eux151.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Kottmaier M, Reents T, Bourier F, Busch S, Semmler V, Telishevska M, Deiss M, Koch-Buettner K, Lengauer S, Kornmayer M, Brooks S, Rousseva E, Hessling G, Deisenhofer I. P886Long-standing persistent atrial fibrillation: The impact of intraprocedural AF termination on freedom of any atrial arrhythmia. Europace 2017. [DOI: 10.1093/ehjci/eux151.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Kabbani LS, Munie S, Lin J, Velez M, Isseh I, Brooks S, Leix S, Shepard AD. Flow Patterns in the Carotid Arteries of Patients with Left Ventricular Assist Devices. Ann Vasc Surg 2017; 39:182-188. [DOI: 10.1016/j.avsg.2016.05.119] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2016] [Revised: 05/13/2016] [Accepted: 05/15/2016] [Indexed: 10/21/2022]
|
48
|
Lewis S, Holl H, Long MT, Mallicote M, Brooks S. 0347 Candidate gene and marker for equine metabolic syndrome. J Anim Sci 2016. [DOI: 10.2527/jam2016-0347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Holl H, Vanhnasy J, Everts R, Cook D, Brooks S, Carpenter M, Bustamante C, Lafayette C. P4046 Development and evaluation of a set of 100 SNP markers for DNA typing in the domestic horse. J Anim Sci 2016. [DOI: 10.2527/jas2016.94supplement4101a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
Iglesias-Bartolome R, Edwards D, Molinolo A, Brooks S, Doci C, Abusleme L, Moutsopoulos N, Gutkind J, Morasso M. 711 The molecular anatomy of human oral and cutaneous wound healing. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|